Literature DB >> 23359065

Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images.

Arnold F Jacobson1, Dale T Matsuoka.   

Abstract

PURPOSE: In planar (123)I-mIBG myocardial imaging, definition of the heart region of interest (ROI) is a critical step in quantifying uptake. The present study evaluated the impact of changes in heart ROI size on quantitative results in subjects with good and poor uptake.
METHODS: Reference irregular whole-heart and square upper mediastinum ROIs were defined visually on 531 planar (123)I-mIBG images. Based on the reference heart ROI, an automated program created two other ROIs: one larger (+1 pixel) and one smaller (-1 pixel), the stated numbers representing the spacing intervals between each epicardial boundary pixel. Two additional smaller ROIs (-2 and -3 pixels) were drawn for the 100 images (19 %) with a heart/mediastinum (H/M) ratio ≤1.30. The number of pixels, the counts per pixel, and the H/M ratio for each heart ROI were calculated and compared to that in the reference ROI. Washout rate and changes as a function of ROI size were also calculated for 110 subjects who had both early and late images.
RESULTS: The mean changes in heart ROI size ranged from +19.0 % for the +1 pixel to -44.4 % for the -3 pixels ROI. For the +1 and -1 pixel ROIs, mean relative counts per pixel changes were -1.2 % and +0.7 %, respectively, with corresponding ranges of change in the H/M ratio of -0.12 to +0.05 and -0.05 to +0.11. For scans with H/M ratio ≤1.30, mean relative counts per pixel changes were 0, 0, -0.7 %, and -1.4 % for the four ROIs, with range of change in the H/M ratio from -0.13 to +0.05. Mean washout rates were almost identical for the reference ROIs (45.0 %) and the +1 pixel and -1 pixel heart ROIs (44.9 % and 45.1 %, respectively).
CONCLUSION: Significant changes in the size of the best visually defined heart ROI produce minimal, clinically inconsequential changes in the H/M ratio and washout rate, even in subjects with significantly reduced myocardial uptake of (123)I-mIBG.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359065     DOI: 10.1007/s00259-012-2336-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  24 in total

1.  123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects.

Authors:  Hein J Verberne; G Aernout Somsen; Berthe L F van Eck-Smit
Journal:  Nucl Med Commun       Date:  2009-06       Impact factor: 1.690

Review 2.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

3.  Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts.

Authors:  T Nakata; K Miyamoto; A Doi; H Sasao; T Wakabayashi; H Kobayashi; K Tsuchihashi; K Shimamoto
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

4.  Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.

Authors:  A Cohen-Solal; Y Esanu; D Logeart; F Pessione; C Dubois; G Dreyfus; R Gourgon; P Merlet
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

5.  Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies.

Authors:  G Aernout Somsen; Hein J Verberne; Eric Fleury; Alberto Righetti
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 6.  Imaging cardiac neuronal function and dysfunction.

Authors:  Takahiro Higuchi; Markus Schwaiger
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

7.  123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study.

Authors:  Jeroen J Bax; Otakar Kraft; Alfred E Buxton; Jan Gunnar Fjeld; Petr Parízek; Denis Agostini; Juhani Knuuti; Albert Flotats; James Arrighi; Africa Muxi; Marie-Jeanne Alibelli; Gopa Banerjee; Arnold F Jacobson
Journal:  Circ Cardiovasc Imaging       Date:  2008-07-30       Impact factor: 7.792

8.  123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.

Authors:  Arnold F Jacobson; John Lombard; Gopa Banerjee; Paolo G Camici
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

Review 9.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 10.057

10.  Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.

Authors:  Hein J Verberne; Jan B A Habraken; Berthe L F van Eck-Smit; Denis Agostini; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-06       Impact factor: 9.236

View more
  5 in total

1.  Quantification of I-123-meta-iodobenzylguanidine heart-to-mediastinum ratios: not so simple after all.

Authors:  Piotr J Slomka; Puja K Mehta; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2014-07-09       Impact factor: 5.952

2.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

Authors:  Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-06       Impact factor: 5.952

Review 3.  Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.

Authors:  Shuchita Gupta; Aman Amanullah
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

4.  Influence of ROI definition on the heart-to-mediastinum ratio in planar 123I-MIBG imaging.

Authors:  Christiane Klene; Christiane Jungen; Koichi Okuda; Yuske Kobayashi; Annabelle Helberg; Janos Mester; Christian Meyer; Kenichi Nakajima
Journal:  J Nucl Cardiol       Date:  2016-11-01       Impact factor: 5.952

5.  4-[18F]Fluoro-m-hydroxyphenethylguanidine: a radiopharmaceutical for quantifying regional cardiac sympathetic nerve density with positron emission tomography.

Authors:  Keun Sam Jang; Yong-Woon Jung; Guie Gu; Robert A Koeppe; Phillip S Sherman; Carole A Quesada; David M Raffel
Journal:  J Med Chem       Date:  2013-09-05       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.